Millennium Management LLC lowered its stake in shares of Humana Inc (NYSE:HUM) by 1.3% in the fourth quarter, according to its most recent disclosure with the SEC. The fund owned 795,738 shares of the insurance provider’s stock after selling 10,390 shares during the period. Millennium Management LLC owned approximately 0.58% of Humana worth $197,399,000 as of its most recent filing with the SEC.
Several other institutional investors and hedge funds also recently made changes to their positions in HUM. Janus Henderson Group PLC raised its position in shares of Humana by 74.1% during the third quarter. Janus Henderson Group PLC now owns 2,729,248 shares of the insurance provider’s stock valued at $664,921,000 after buying an additional 1,161,661 shares during the last quarter. APG Asset Management N.V. raised its position in shares of Humana by 60.3% during the fourth quarter. APG Asset Management N.V. now owns 729,519 shares of the insurance provider’s stock valued at $150,709,000 after buying an additional 274,435 shares during the last quarter. Bank of Montreal Can raised its position in shares of Humana by 118.3% during the fourth quarter. Bank of Montreal Can now owns 501,379 shares of the insurance provider’s stock valued at $124,378,000 after buying an additional 271,701 shares during the last quarter. Virtus Fund Advisers LLC raised its position in shares of Humana by 116.8% during the fourth quarter. Virtus Fund Advisers LLC now owns 423,275 shares of the insurance provider’s stock valued at $105,171,000 after buying an additional 228,050 shares during the last quarter. Finally, Hudson Bay Capital Management LP raised its position in shares of Humana by 785.6% during the fourth quarter. Hudson Bay Capital Management LP now owns 221,398 shares of the insurance provider’s stock valued at $54,922,000 after buying an additional 196,398 shares during the last quarter. 97.85% of the stock is owned by institutional investors and hedge funds.
In other Humana news, CEO Bruce D. Broussard sold 14,075 shares of the company’s stock in a transaction dated Monday, February 26th. The shares were sold at an average price of $274.32, for a total transaction of $3,861,054.00. Following the sale, the chief executive officer now directly owns 113,896 shares of the company’s stock, valued at $31,243,950.72. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, SVP Cynthia H. Zipperle sold 1,196 shares of the company’s stock in a transaction dated Friday, March 9th. The stock was sold at an average price of $273.33, for a total transaction of $326,902.68. Following the sale, the senior vice president now directly owns 7,771 shares in the company, valued at $2,124,047.43. The disclosure for this sale can be found here. Insiders have sold 41,775 shares of company stock worth $11,169,845 over the last ninety days. Insiders own 0.60% of the company’s stock.
Humana (NYSE:HUM) last issued its quarterly earnings data on Wednesday, February 7th. The insurance provider reported $2.06 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $2.00 by $0.06. The firm had revenue of $13.19 billion for the quarter, compared to analysts’ expectations of $13.14 billion. Humana had a net margin of 4.55% and a return on equity of 16.13%. The company’s quarterly revenue was up 2.4% compared to the same quarter last year. During the same period in the prior year, the firm earned $2.34 earnings per share. sell-side analysts predict that Humana Inc will post 13.81 EPS for the current fiscal year.
Humana announced that its Board of Directors has authorized a stock buyback program on Thursday, December 14th that permits the company to buyback $3.00 billion in outstanding shares. This buyback authorization permits the insurance provider to purchase shares of its stock through open market purchases. Shares buyback programs are usually a sign that the company’s management believes its shares are undervalued.
The company also recently disclosed a quarterly dividend, which will be paid on Friday, April 27th. Shareholders of record on Friday, March 30th will be paid a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a yield of 0.74%. This is a boost from Humana’s previous quarterly dividend of $0.40. The ex-dividend date of this dividend is Wednesday, March 28th. Humana’s dividend payout ratio is currently 9.59%.
HUM has been the subject of a number of research analyst reports. Jefferies Group raised shares of Humana from a “hold” rating to a “buy” rating and set a $221.00 price objective for the company in a research report on Friday, January 12th. Cantor Fitzgerald reaffirmed a “hold” rating and set a $230.00 price objective on shares of Humana in a research report on Tuesday, December 5th. Zacks Investment Research cut shares of Humana from a “strong-buy” rating to a “hold” rating in a research note on Friday, January 19th. Credit Suisse Group raised shares of Humana from a “neutral” rating to an “outperform” rating and lowered their target price for the company from $264.90 to $246.00 in a research note on Thursday, February 8th. Finally, Goldman Sachs Group began coverage on shares of Humana in a research note on Wednesday, January 3rd. They issued a “buy” rating and a $305.00 target price on the stock. Eight investment analysts have rated the stock with a hold rating and fourteen have assigned a buy rating to the company’s stock. The company currently has a consensus rating of “Buy” and an average price target of $270.47.
WARNING: This article was originally published by American Banking News and is owned by of American Banking News. If you are reading this article on another publication, it was copied illegally and reposted in violation of United States & international copyright and trademark legislation. The legal version of this article can be viewed at https://www.americanbankingnews.com/2018/03/14/humana-inc-hum-shares-sold-by-millennium-management-llc.html.
Humana Company Profile
Humana Inc is a health and well-being company. The Company’s segments include Retail, Group and Specialty, Healthcare Services and Individual Commercial. The Retail segment consists of Medicare benefits, as well as individual commercial fully insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products.
Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.